Skip to main content

Hashtag araması

#OraklOncology, a French #TechBio company using AI and real patient biology to predict how #cancer drugs will perform in clinical trials, today announced a €30 million #SeriesA 🇫🇷 🧬

Read more: https://t.co/NjWSrpilPC
4
Sona ulaştın 🎉